Literature DB >> 10066652

Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064.

H Yasui1, J Kiyoshima, T Hori, K Shida.   

Abstract

Mice fed Bifidobacterium breve YIT4064 and immunized orally with influenza virus were more strongly protected against influenza virus infection of the lower respiratory tract than ones immunized with influenza virus only. The number of mice with enhanced anti-influenza virus immunoglobulin G (IgG) in serum upon oral administration of B. breve YIT4064 and oral immunization with influenza virus was significantly greater than that upon oral immunization with influenza virus only. These findings demonstrated that the oral administration of B. breve YIT4064 increased anti-influenza virus IgG antibodies in serum and protected against influenza virus infection. The oral administration of B. breve YIT4064 may enhance antigen-specific IgG against various pathogenic antigens taken orally and induce protection against various virus infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10066652      PMCID: PMC95685          DOI: 10.1128/CDLI.6.2.186-192.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  26 in total

1.  Primary isolation of influenza A, B, and C viruses in monkey kidney tissue cultures.

Authors:  K K TAKEMOTO; R K LYNT; W P ROWE; R J HUEBNER; J A BELL; G W MELLIN; D J DAVIS
Journal:  Proc Soc Exp Biol Med       Date:  1955-06

2.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.

Authors:  M L Clements; R F Betts; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

3.  Pulmonary and serum isotypic antibody responses of mice to live and inactivated influenza virus.

Authors:  E S Balkovic; H R Six
Journal:  Am Rev Respir Dis       Date:  1986-07

Review 4.  Biology of the bifidobacteria.

Authors:  J A Poupard; I Husain; R F Norris
Journal:  Bacteriol Rev       Date:  1973-06

Review 5.  Immunity to influenza in man.

Authors:  R B Couch; J A Kasel
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

6.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.

Authors:  K S Chen; D B Burlington; G V Quinnan
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

8.  Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice.

Authors:  R G Webster; B A Askonas
Journal:  Eur J Immunol       Date:  1980-05       Impact factor: 5.532

9.  Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis.

Authors:  R Ramphal; R C Cogliano; J W Shands; P A Small
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

10.  Origin and fate of IgE-bearing lymphocytes. I. Peyer's patches as differentiation site of cells. Simultaneously bearing IgA and IgE.

Authors:  H G Durkin; H Bazin; B H Waksman
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  25 in total

1.  Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice.

Authors:  T Hori; J Kiyoshima; K Shida; H Yasui
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Improvement of Redox State and Functions of Immune Cells as Well as of Behavioral Response in Aged Mice After Two-Week Supplementation of Fermented Milk with Probiotics.

Authors:  Caroline Hunsche; Julia Cruces; Mónica De la Fuente
Journal:  Curr Microbiol       Date:  2019-08-24       Impact factor: 2.188

3.  Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial.

Authors:  Gen Sugawara; Masato Nagino; Hideki Nishio; Tomoki Ebata; Kenji Takagi; Takashi Asahara; Koji Nomoto; Yuji Nimura
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

4.  Enhanced antigen-specific delayed-type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT9029 in Wistar and Brown Norway rats.

Authors:  R de Waard; J Garssen; J Snel; G C Bokken; T Sako; J H Veld; J G Vos
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

5.  Swine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis?

Authors:  Naoyoshi Maeda; Toshimitsu Uede
Journal:  World J Biol Chem       Date:  2010-05-26

6.  Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota.

Authors:  Tetsuji Hori; Junko Kiyoshima; Kan Shida; Hisako Yasui
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

7.  Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota.

Authors:  Hisako Yasui; Junko Kiyoshima; Tetsuji Hori
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

Review 8.  Interactions between commensal bacteria and viral infection: insights for viral disease control in farmed animals.

Authors:  Chao Ran; Yu Li; Xufa Ma; Yadong Xie; Mingxu Xie; Yuting Zhang; Wei Zhou; Yalin Yang; Zhen Zhang; Li Zhou; Kaijian Wei; Zhigang Zhou
Journal:  Sci China Life Sci       Date:  2021-01-06       Impact factor: 6.038

9.  Intake of korean red ginseng extract and saponin enhances the protection conferred by vaccination with inactivated influenza a virus.

Authors:  Mei Ling Xu; Hyoung Jin Kim; Yoo Ri Choi; Hong-Jin Kim
Journal:  J Ginseng Res       Date:  2012-10       Impact factor: 6.060

Review 10.  Probiotics in the management of lung diseases.

Authors:  Esmaeil Mortaz; Ian M Adcock; Gert Folkerts; Peter J Barnes; Arjan Paul Vos; Johan Garssen
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.